Recordati - Industria Chimica e Farmaceutica S.p.A. financial statements, including revenue, expenses, profit, and loss

The total revenue of RER1 for the last quarter is 607.82 M EUR, and it's 15.52% higher compared to the previous quarter. The net income of Q1 24 is 123.59 M EUR.